Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Parkinson's DiseaseDeep Brain Stimulation Surgery
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine infusion will be started with a loading dose of 1 mcg/Kg over ten to 20 minutes followed by a maintenance infusion of 0.7 mcg/Kg/hr until stable sedation is achieved.

Trial Locations (1)

53705

University of Wisconsin - Madison, School of Medicine and Public Health, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01721460 - Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus | Biotech Hunter | Biotech Hunter